- Home
- WISTEM2d
What WiSTEM²D is—and why it matters
Johnson & Johnson has invested in the STEM2D workforce to giving them the tools, resources and opportunities to succeed at work and at home since our founding more than 138 years ago.
Furthering that commitment, in 2015 we launched our WiSTEM2D initiative. WiSTEM2D stands for Winning in Science, Technology, Engineering, Math, Manufacturing and Design. We believe the STEM2D workforce can be catalysts for creating healthier people, healthier communities and a healthier world.
At J&J, we are dedicated to the values in Our Credo. We aim to inspire and empower all employees on their STEM2D journeys through access, engagement and skill development. Together, we believe STEM2D professionals are powerful catalysts for change in the world.
At J&J, we are dedicated to the values in Our Credo. We aim to inspire and empower all employees on their STEM2D journeys through access, engagement and skill development. Together, we believe STEM2D professionals are powerful catalysts for change in the world.
Supporting youth
Johnson & Johnson seeks to cultivate STEM2D interest at an early age to help youth grow and develop in these areas, preparing and positioning them to pursue higher education and careers in STEM2D. Through creative problem-solving and play, we aim to spark enchantment with STEM2D subjects in young people around the globe.
Supporting professionals
At Johnson & Johnson, we believe inclusive teams broaden viewpoints, allowing greater potential for new discoveries and innovations. To that end, we are championing the power of many perspectives through reimagined attraction and development of the world’s best STEM2D talent.
-
The WiSTEM2D program is continuing to blend our heart, science and ingenuity to profoundly impact health for humanity for the next generation of leaders. We do so by building partnerships to open new doors, creating inspiring moments to honor all in STEM2D, playing the part of role models and mentoring one another throughout the fundamental stages of our lives.
Kathy WengelExecutive Vice President & Chief Technical Operations & Risk Officer
More from Johnson & Johnson
What is cardiac ablation?
Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
Using your own cells to fight cancer
Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson has treated more than 10,000 patients and counting with this cutting-edge therapy.
What are biologics?
Biologics, a class of medications derived from living organisms, treat a range of conditions including immune-mediated diseases and cancer. Learn how Johnson & Johnson is innovating in biologics to improve treatment options for people around the world.